Jpmorgan Chase & CO 4 D Molecular Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 886,705 shares of FDMT stock, worth $5.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
886,705
Previous 820,069 8.13%
Holding current value
$5.45 Million
Previous $4.57 Million 37.29%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$3.23 - $6.6 $215,234 - $439,797
66,636 Added 8.13%
886,705 $2.86 Million
Q4 2024

Feb 12, 2025
BUY
$5.3 - $10.41 $2.67 Million - $5.25 Million
504,086 Added 159.53%
820,069 $4.57 Million
Q3 2024

Dec 26, 2024
SELL
$10.81 - $27.22 $322,029 - $810,883
-29,790 Reduced 8.62%
315,983 $3.42 Million
Q3 2024

Nov 08, 2024
SELL
$10.81 - $27.22 $322,029 - $810,883
-29,790 Reduced 8.62%
315,983 $3.42 Million
Q2 2024

Dec 26, 2024
BUY
$20.93 - $30.01 $623,504 - $893,997
29,790 Added 9.43%
345,773 $7.26 Million
Q2 2024

Aug 12, 2024
SELL
$20.93 - $30.01 $1.19 Million - $1.7 Million
-56,768 Reduced 14.1%
345,773 $7.26 Million
Q1 2024

Dec 26, 2024
BUY
$17.03 - $35.87 $1.47 Million - $3.1 Million
86,558 Added 27.39%
402,541 $12.8 Million
Q1 2024

May 10, 2024
SELL
$17.03 - $35.87 $440,208 - $927,203
-25,849 Reduced 6.03%
402,541 $12.8 Million
Q4 2023

Dec 26, 2024
BUY
$9.76 - $21.25 $1.1 Million - $2.39 Million
112,407 Added 35.57%
428,390 $8.68 Million
Q4 2023

Feb 12, 2024
SELL
$9.76 - $21.25 $1.53 Million - $3.34 Million
-157,061 Reduced 26.83%
428,390 $8.68 Million
Q3 2023

Nov 14, 2023
BUY
$12.64 - $19.76 $1.62 Million - $2.53 Million
128,237 Added 28.05%
585,451 $7.45 Million
Q2 2023

Aug 11, 2023
BUY
$15.16 - $23.26 $256,219 - $393,117
16,901 Added 3.84%
457,214 $8.26 Million
Q1 2023

May 18, 2023
BUY
$15.45 - $23.19 $355,180 - $533,114
22,989 Added 5.51%
440,313 $7.57 Million
Q1 2023

May 11, 2023
SELL
$15.45 - $23.19 $349,942 - $525,253
-22,650 Reduced 5.15%
417,324 $7.17 Million
Q4 2022

Feb 13, 2023
SELL
$6.85 - $25.46 $89,967 - $334,391
-13,134 Reduced 2.9%
439,974 $9.77 Million
Q3 2022

Nov 14, 2022
SELL
$6.96 - $11.48 $178,517 - $294,450
-25,649 Reduced 5.36%
453,108 $3.64 Million
Q2 2022

Aug 11, 2022
BUY
$5.68 - $15.99 $631,684 - $1.78 Million
111,212 Added 30.26%
478,757 $3.34 Million
Q1 2022

May 11, 2022
BUY
$13.16 - $22.64 $1.11 Million - $1.91 Million
84,158 Added 29.7%
367,545 $5.56 Million
Q4 2021

Feb 10, 2022
BUY
$19.56 - $32.94 $1.05 Million - $1.76 Million
53,451 Added 23.25%
283,387 $6.22 Million
Q3 2021

Nov 12, 2021
BUY
$22.73 - $36.04 $5.23 Million - $8.29 Million
229,936 New
229,936 $6.2 Million

Others Institutions Holding FDMT

# of Institutions
126
Shares Held
41.9M
Call Options Held
19K
Put Options Held
38.3K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $199M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email